#USA #Orlando #ModuleMD #SkinSight AI #JOSH

ModuleMD Unveils Game-Changing AI Allergy Solutions at ACAAI 2025

This November, the ACAAI Annual Meeting 2025 held in Orlando, Florida, buzzed with discussions about the future of allergy care, dominated by the theme of artificial intelligence and its transformative potential. ModuleMD, a leader in allergy technology, made waves by showcasing cutting-edge advancements, including their flagship feature, SkinSight AI. This technology promises to revolutionize the way allergists operate, improving clinical efficiency and patient care immeasurably.

A New Dawn in Allergy Care

Unlike traditional electronic health record systems that force clinicians to adjust their workflows, ModuleMD's platform is purposefully crafted to meet the specific needs of the allergy and immunology field. This ensures that healthcare providers can integrate the technology seamlessly into their practices, enhancing their efficiency right from the start.

At the heart of ModuleMD's offerings was SkinSight AI, an innovative clinical decision-support tool. Designed to assist allergists in making informed treatment choices, SkinSight AI evaluates skin test results through objective and standardized data. Upon ordering a skin test panel, the system activates, capturing an image and automatically detecting positive reactions—all while delivering precise wheal and flare measurements for each allergen tested. This advancement eliminates manual interpretation errors and accelerates documentation processes significantly.

Immediate Benefits for Clinicians

With SkinSight AI, allergists can instantly identify which allergens are causing reactions and gauge the intensity of these responses. Results flow directly into the patient's electronic chart, transforming what used to be a cumbersome and subjective process into a quick, uniform workflow. The current capabilities of this advanced tool featured at the conference included:

• - Automatic detection of positive skin test reactions
• - Exact measurements of wheal and flare for individual allergens
• - Instant documentation in the patient's chart
• - Support for standardizing intradermal tests
• - Quick insights into reacting allergens

Looking ahead, future enhancements for SkinSight AI are set to include tracking fluctuations in reactions across multiple patient visits, showing patients their progress over the course of immunotherapy, and enabling patients to access their results, which could foster better compliance and adherence to treatment protocols.

Who is JOSH?

In addition to SkinSight AI, ModuleMD also showcased JOSH, an advanced dictation and documentation assistant. JOSH provides real-time, high-accuracy voice recognition, allowing allergists to pause and resume dictation seamlessly across various patients—a particularly useful feature in the fast-paced environment of allergy treatment. Supporting over 75 languages, JOSH diminishes the documentation burden and enhances service for diverse patient groups.

Streamlining Workflow with SPOCK

SPOCK, another innovative offering from ModuleMD, stood out as a comprehensive workflow and front-office coordination tool. This single interface allows practices to manage patient scheduling, reminders, and communications effectively. SPOCK enhances operational efficiency for practices handling high patient volumes with intricate schedules, thereby improving the overall patient experience from arrival to follow-up appointments.

Enhancing Insights with InDrA

Lastly, the presentation of InDrA, ModuleMD's data analytics engine, highlighted how practices can extract valuable insights from their data. This tool assists in monitoring performance and identifying trends, thereby supporting better decision-making and sustainable growth in allergy practices.

The Future of Allergy Care

“Our mission is to empower allergists with technology that boosts clinical confidence and optimizes patient outcomes,” said Abhinay Rao, CEO of ModuleMD. “At this year’s ACAAI, SkinSight AI exemplified the power of innovation tailored specifically to the workflows of specialists. Coupled with JOSH, SPOCK, and InDrA, we are providing an all-encompassing, intelligent ecosystem that allows clinicians to work smarter and deliver exceptional care.”

The feedback from attendees at the conference was overwhelmingly supportive. Many praised ModuleMD for offering practical, advanced solutions that could be integrated immediately into their daily workflows. SkinSight AI, in particular, was labeled as a “game changer,” introducing essential speed, precision, and objectivity to crucial diagnostic procedures in allergy treatment.

As the conference wrapped up, one thing was unequivocally clear—ModuleMD is not just advancing technology but is setting the pace for the future of allergy and immunology care. With innovative tools like SkinSight AI leading the charge, and supportive applications like JOSH, SPOCK, and InDrA enriching the overall ecosystem, ModuleMD is dedicated to enabling allergists to document efficiently and provide unparalleled care amid an era of intelligent healthcare.